The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults
NCT ID: NCT01040702
Last Updated: 2009-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
58 participants
INTERVENTIONAL
2008-01-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ADHD -MPH
adults with ADHD diagnosis who receive a single dose of Methylphenidate
methylphenidate
a single doses of 10-20 mg in each one of two visits
ADHD-placebo
adults with ADHD diagnosis who received placebo
sweetener pill
a capsule containing a sweetener pill
non-ADHD-MPH
healthy adults who received a single dose of Methylphenidate
methylphenidate
a single doses of 10-20 mg in each one of two visits
non-ADHD-placebo
healthy adults who received placebo
sweetener pill
a capsule containing a sweetener pill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
methylphenidate
a single doses of 10-20 mg in each one of two visits
sweetener pill
a capsule containing a sweetener pill
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* people who suffer from a psychiatric disorder other than ADHD which could account for their inattention symptoms better than ADHD.
* people who lack judgment or are unable to communicate with the experimenters.
* people who are incapable of performing the computerized tasks due to sensory or motor disabilities.
21 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shalvata Mental Health Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shalvata MHC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ziv Carmel, MD
Role: PRINCIPAL_INVESTIGATOR
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
cognitive laboratory,Shalvata MHC
Hod HaSharon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SH-40107
Identifier Type: -
Identifier Source: org_study_id